Isoschaftoside Reverses Nonalcoholic Fatty Liver Disease via Activating Autophagy <i>In Vivo</i> and <i>In Vitro</i>.

Isoschaftoside Reverses Nonalcoholic Fatty Liver Disease via Activating Autophagy In Vivo and In Vitro.

Su, Yanze; Kang, Yixing; Yi, Jing; Lin, Qirui; Zhang, Chaochuang; Lin, Zewei; Yan, Zilong; Qu, Jianhua; Liu, Jikui.

Afiliación

Su Y; Department of Clinical Medicine, Weifang Medical University, Weifang 261031, China.
Kang Y; Department of Hepatobiliary and Pancreatic Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, China.
Yi J; Department of Clinical Medicine, Weifang Medical University, Weifang 261031, China.
Lin Q; Department of Hepatobiliary and Pancreatic Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, China.
Zhang C; Department of Hepatobiliary and Pancreatic Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, China.
Lin Z; Department of Hepatobiliary and Pancreatic Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, China.
Yan Z; Department of Hepatobiliary and Pancreatic Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, China.
Qu J; Department of Hepatobiliary and Pancreatic Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, China.
Liu J; Department of Hepatobiliary and Pancreatic Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, China.

Evid Based Complement Alternat Med ; 2022: 2122563, 2022.

Article en En | MEDLINE | ID: mdl-35795282

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2022 Tipo del documento: Article